Format

Send to

Choose Destination
J Periodontol. 2018 Jun;89 Suppl 1:S74-S84. doi: 10.1002/JPER.17-0719.

Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.

Author information

1
Periodontal Research Group, Institute of Clinical Sciences, College of Medical & Dental Sciences, University of Birmingham, UK.
2
University of Texas Health Science Center at San Antonio, USA.
3
The Forsyth Institute, Cambridge, MA, USA.
4
School of Dentistry, University of Adelaide, Australia.
5
Department of Periodontology and Synoptic Dentistry, Charité - Universitätsmedizin Berlin, Germany.
6
Department of Periodontology, Center for Oral Medicine, Johann Wolfgang Goethe-University Frankfurt, Germany.
7
Department of Periodontology, University of Alabama at Birmingham, USA.
8
Department of Oral Biology, SUNY at Buffalo, NY, USA.
9
Faculty of Dentistry, University of Toronto, Canada.
10
Department of Periodontology, Faculty of Dental Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
11
Periodontal Department, Tufts University School of Dental Medicine, Boston, MA, USA.
12
Periodontology, Section 1, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
13
Department of Periodontology, University of Iowa College of Dentistry, Iowa City, IA, USA.
14
Orofacial Sciences, University of California San Francisco, USA.
15
Department of Periodontology, University of Bern, Switzerland.
16
Department of Periodontology, University of Giessen, Germany.
17
Department of Periodontology, Graduate School of Dentistry, Osaka University, Japan.
18
Department of Periodontics, Texas A&M College of Dentistry, Dallas, TX, USA.
19
Division of Periodontology, Department of Stomatology, Dental School, University of São Paulo, Brazil.
20
Division of Periodontology, College of Dentistry, Ohio State University, Columbus, OH, USA.
21
Department of Oral Health Sciences, Periodontology, KU Leuven & Dentistry, University Hospitals Leuven, Belgium.
22
Research Center for the Study of Periodontal and Peri-Implant Diseases, University of Ferrara, Italy.
23
Department of Periodontology, Endodontology & Cariology, University Centre for Dental Medicine, University of Basel School of Dentistry, Switzerland.
24
Department of Prosthodontics, School of Dentistry, Medical University Graz, Austria.
25
Orofacial Sciences, School of Dentistry, University of California San Francisco, USA.
26
Division of Periodontology, Niigata University Graduate School of Medical and Dental Sciences, Japan.

Abstract

Periodontal health is defined by absence of clinically detectable inflammation. There is a biological level of immune surveillance that is consistent with clinical gingival health and homeostasis. Clinical gingival health may be found in a periodontium that is intact, i.e. without clinical attachment loss or bone loss, and on a reduced periodontium in either a non-periodontitis patient (e.g. in patients with some form of gingival recession or following crown lengthening surgery) or in a patient with a history of periodontitis who is currently periodontally stable. Clinical gingival health can be restored following treatment of gingivitis and periodontitis. However, the treated and stable periodontitis patient with current gingival health remains at increased risk of recurrent periodontitis, and accordingly, must be closely monitored. Two broad categories of gingival diseases include non-dental plaque biofilm-induced gingival diseases and dental plaque-induced gingivitis. Non-dental plaque biofilm-induced gingival diseases include a variety of conditions that are not caused by plaque and usually do not resolve following plaque removal. Such lesions may be manifestations of a systemic condition or may be localized to the oral cavity. Dental plaque-induced gingivitis has a variety of clinical signs and symptoms, and both local predisposing factors and systemic modifying factors can affect its extent, severity, and progression. Dental plaque-induced gingivitis may arise on an intact periodontium or on a reduced periodontium in either a non-periodontitis patient or in a currently stable "periodontitis patient" i.e. successfully treated, in whom clinical inflammation has been eliminated (or substantially reduced). A periodontitis patient with gingival inflammation remains a periodontitis patient (Figure 1), and comprehensive risk assessment and management are imperative to ensure early prevention and/or treatment of recurrent/progressive periodontitis. Precision dental medicine defines a patient-centered approach to care, and therefore, creates differences in the way in which a "case" of gingival health or gingivitis is defined for clinical practice as opposed to epidemiologically in population prevalence surveys. Thus, case definitions of gingival health and gingivitis are presented for both purposes. While gingival health and gingivitis have many clinical features, case definitions are primarily predicated on presence or absence of bleeding on probing. Here we classify gingival health and gingival diseases/conditions, along with a summary table of diagnostic features for defining health and gingivitis in various clinical situations.

KEYWORDS:

Crohn's disease; Hodgkin lymphoma; Melkersson-Rosenthal; Mycobacterium tuberculosis; Neisseria gonorrhoeae; Treponema pallidum; allergic reaction; amalgam tattoo; aspergillosis; biofilm; blastomycosis; calcifying fibroblastic granuloma; candidosis; chemical trauma; clinical health; coccidioidomycosis; condylomata acuminatum; contact allergy; coxsackie virus; dental plaque-induced gingivitis; disease control; disease remission; disease stability; drug-induced gingival enlargement; drug-induced pigmentation; dysbiosis; erythema multiforme; erythroplakia; factitious injury; fibrous epulis; focal epithelial hyperplasia; frictional keratosis; geotricosis; gingival pigmentation; hand foot and mouth; hereditary gingival fibromatosis; herpangina; herpes simplex; histoplasmosis; hyperglycemia; hyposalivation; intact periodontium; leukemia; leukoplakia; lichen planus; local risk factors; lupus erythematosus; melanoplakia; menstrual cycle; modifying factors; molluscum contagiosum; mucormycosis; necrotizing periodontal diseases; non-Hodgkin lymphoma; non-dental plaque-induced gingival conditions; oral contraceptive; orofacial granulomatosis; paracoccidioidomycosis; pemphigoid; pemphigus vulgaris; periodontal disease; peripheral giant cell granuloma; plasma cell gingivitis; predisposing factors; pregnancy; puberty; pyogenic granuloma; reduced periodontium; resolution of inflammation; restoration margins; sarcoidosis; scurvy; smoker's melanosis; smoking; squamous cell carcinoma; squamous cell papilloma; stable periodontitis; streptoccocal gingivitis; symbiosis; systemic risk factors; thermal trauma; toothbrush trauma; varicella zoster; vascular epulis; verruca vulgaris

PMID:
29926944
DOI:
10.1002/JPER.17-0719

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center